UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Deciding which card is better, cash back or rewards, requires consideration of your spending habits. Make the right choice for your finances.
26,157 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
D-Wave Quantum stock is rallying on recent funding news and government support. This guide breaks down what that mean...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
Imagine earning real estate profits without tying up your cash or buying a property. This guide breaks down seven loa...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
You don’t have to pause your career to claim Social Security. This guide explains how to collect social security whil...
In a volatile start to 2026, investors are seeking dividend ETFs built survive strategies that combine durable income...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
BlackRock launches BITA, a Bitcoin Premium Income ETF that channels crypto volatility into monthly distributions via ...
Investors are weighing whether now is the time to buy SpaceX's stock after a pullback. This guide breaks down the dec...
EVgo’s growth hinges on expanding its fast-charging network and capitalizing on policy support. This article outlines...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...